The presence of a fibrotic focus is an independent predictor of early metastasis in lymph node-negative breast cancer patients.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 11717549)

Published in Am J Surg Pathol on December 01, 2001

Authors

C Colpaert, P Vermeulen, E Van Marck, L Dirix

Articles citing this

Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol (2006) 6.64

An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol (2009) 3.15

The rationale for targeting the LOX family in cancer. Nat Rev Cancer (2012) 2.02

Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. Nat Cell Biol (2015) 1.54

Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis. Clin Cancer Res (2014) 1.17

Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers. J Transl Med (2008) 1.15

Engineering strategies to recapitulate epithelial morphogenesis within synthetic three-dimensional extracellular matrix with tunable mechanical properties. Phys Biol (2011) 1.07

PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV. Mol Endocrinol (2013) 0.97

Forcing through Tumor Metastasis: The Interplay between Tissue Rigidity and Epithelial-Mesenchymal Transition. Trends Cell Biol (2015) 0.87

Lysyl oxidase: a potential target for cancer therapy. Inflammopharmacology (2010) 0.84

Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion. Adv Exp Med Biol (2015) 0.83

GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2. Cancer Res (2013) 0.82

Stromal interactions as regulators of tumor growth and therapeutic response: A potential target for photodynamic therapy? Isr J Chem (2012) 0.78

The 2016 John J. Abel Award Lecture: Targeting the Mechanical Microenvironment in Cancer. Mol Pharmacol (2016) 0.75

Articles by these authors

Nonthrombotic pulmonary embolism. Eur Respir J (2009) 2.93

Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer (2002) 2.82

Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors? Trans R Soc Trop Med Hyg (2002) 2.63

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol (2007) 2.24

Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol (1991) 2.08

Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br J Cancer (1999) 1.81

Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. J Clin Oncol (2000) 1.77

Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. Br J Cancer (1998) 1.64

Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol (2001) 1.57

Preoperative breast MRI in patients with invasive lobular breast cancer. Eur Radiol (2004) 1.55

Cystosarcoma phyllodes of the prostate with rhabdomyoblastic differentiation. Pathol Res Pract (2001) 1.49

Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer. Br J Cancer (2006) 1.46

Spherocytosis and pulmonary hypertension coincidental occurrence or causal relationship? Eur Respir J (1991) 1.43

Isolation of markers for chondro-osteogenic differentiation using cDNA library subtraction. Molecular cloning and characterization of a gene belonging to a novel multigene family of integral membrane proteins. J Biol Chem (1996) 1.42

Primary extrauterine müllerian adenosarcoma of the peritoneum. Gynecol Oncol (1995) 1.41

Tyramine-amplified immunohistochemical testing using "homemade" biotinylated tyramine is highly sensitive and cost-effective. Arch Pathol Lab Med (1998) 1.40

The unexpected thyroid cancer: surgical attitude. Acta Chir Belg (1995) 1.39

The influence of a pneumoperitoneum on the peritoneal implantation of free intraperitoneal colon cancer cells. Surg Endosc (1996) 1.38

Rhodococcus equi infection in 3 AIDS patients. Acta Clin Belg (1996) 1.38

alphaT-catenin: a novel tissue-specific beta-catenin-binding protein mediating strong cell-cell adhesion. J Cell Sci (2001) 1.35

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer. Ann Oncol (2003) 1.35

Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer (2002) 1.31

Prognostic value of bcl-2 expression in invasive breast cancer. Br J Cancer (1995) 1.30

Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma. Eur J Hum Genet (2003) 1.25

Early distant relapse in "node-negative" breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. J Pathol (2001) 1.24

Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy. Ann Oncol (2012) 1.22

MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MRI-pathology study of 21 cases and literature review. Skeletal Radiol (2000) 1.21

Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry. J Am Soc Mass Spectrom (2003) 1.21

Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome. J Pathol (1998) 1.21

Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients. Clin Cancer Res (1998) 1.21

Intrathoracic hibernoma: report of two cases. Lung Cancer (2009) 1.21

Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol (2000) 1.20

Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol (2000) 1.19

Telomeres, telomerase and cancer: an up-date. Virchows Arch (2000) 1.18

Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas. Ann Oncol (1995) 1.18

Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis. Br J Cancer (2007) 1.17

Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol (2004) 1.16

Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. Br J Cancer (1995) 1.16

The association of meningioma and pituitary adenoma: report of seven cases and review of the literature. Eur Neurol (1993) 1.16

Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breast cancer patients. Histopathology (2001) 1.13

New concepts in understanding evolution of desmoid tumors: MR imaging of 30 lesions. Eur Radiol (1997) 1.13

Prehospital thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Crit Care Med (1988) 1.13

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer. Ann Oncol (2009) 1.12

Desmoplastic fibroma of bone: MRI features. Skeletal Radiol (2000) 1.12

Comparison of pap smear, visual inspection with acetic acid, human papillomavirus DNA-PCR testing and cervicography. Int J Gynaecol Obstet (2005) 1.12

The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'. Ann Oncol (2004) 1.10

Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression. J Pathol (1999) 1.09

Low-grade chondrosarcoma vs enchondroma: challenges in diagnosis and management. Eur Radiol (2001) 1.08

Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study. Angiogenesis (2001) 1.08

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU). Eur J Cancer (1999) 1.07

Diagnosis of genital cervical schistosomiasis: comparison of cytological, histopathological and parasitological examination. Am J Trop Med Hyg (2001) 1.07

Atypical or worrisome features in cellular neurothekeoma: a study of 10 cases. Am J Surg Pathol (1998) 1.07

Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998-2000. Trop Med Int Health (2002) 1.07

Expression of bcl-2 in invasive and in situ carcinoma of the uterine cervix. Am J Obstet Gynecol (1998) 1.07

Coping with toxicities of docetaxel (Taxotere). Ann Oncol (1993) 1.06

A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors. Clin Cancer Res (1998) 1.05

Malignant melanoma of the soft parts (clear-cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation. Mod Pathol (1997) 1.02

Generalized papular pruritic eruption in African patients with human immunodeficiency virus infection. AIDS (1987) 1.01

Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer. Br J Cancer (2004) 1.00

An unusual case of ectopic tungiasis with pseudoepitheliomatous hyperplasia. Braz J Infect Dis (2005) 1.00

Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study. Br J Cancer (2005) 1.00

Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection. J Am Acad Dermatol (1999) 1.00

Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. Eur Respir J (1997) 0.99

Lack of angiogenesis in lymph node metastases of carcinomas is growth pattern-dependent. Histopathology (2002) 0.98

Evaluation of tumour angiogenesis as a prognostic marker in malignant mesothelioma. J Pathol (1997) 0.98

Immunohistochemical study of topoisomerase II-alpha expression in primary ductal carcinoma of the breast. J Clin Pathol (1995) 0.97

Characterization of the myoglobin and its coding gene of the mollusc Biomphalaria glabrata. J Biol Chem (1998) 0.97

Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries. Br J Surg (2010) 0.96

A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993). Eur J Cancer (2006) 0.96

Postmortem examination of two fragile X brothers with an FMR1 full mutation. Am J Med Genet (1999) 0.96

Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival. Ann Oncol (2013) 0.96

Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer. Br J Cancer (1999) 0.96

A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. Obesity (Silver Spring) (2013) 0.95

Wavelets as chromatin texture descriptors for the automated identification of neoplastic nuclei. J Microsc (2000) 0.95

Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension. Int J Obes (Lond) (2010) 0.95

Lack of association of cytomegalovirus with endemic African Kaposi's sarcoma. J Infect Dis (1987) 0.95

Subcutaneous diffuse neurofibroma of the neck: a case report. J Laryngol Otol (1996) 0.94

Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast. JBR-BTR (2005) 0.94

KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis. Br J Cancer (2010) 0.94

Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma. Eur J Cardiothorac Surg (1997) 0.94

Massive cerebral infarction after completion pneumonectomy for pulmonary torsion. Thorax (1994) 0.93

Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer. Br J Cancer (2002) 0.93

Acute superior vena cava obstruction after rupture of a bronchial artery aneurysm. Chest (1996) 0.93

A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer. Ann Oncol (2012) 0.92

Histomorphometric study of the normal middle ear mucosa. Preliminary results supporting the gas-exchange function in the postero-superior part of the middle ear cleft. Acta Otolaryngol (1997) 0.91